Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Understanding the impact of undiagnosed celiac disease and the potential benefits of diagnosis

Outcome Description:

To understanding the impact of undiagnosed celiac disease and the potential benefits, detection and treatment may have a substantial impact on the health of these subjects and the large numbers of Americans with undiagnosed celiac disease. The outcome measures we will be looking at are Quality of Life, GI Symptoms including diarrhea, constipation, abdominal pain, Tissue Transglutaminase level improvement after 12 weeks on a gluten free diet, bone density, understanding of a gluten free diet.

Outcome Time Frame:

one year

Safety Issue:

No

Principal Investigator

Joseph Murray, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

10-000178

NCT ID:

NCT01317914

Start Date:

July 2010

Completion Date:

April 2012

Related Keywords:

• Celiac Disease
• Celiac Disease